Advanced Filters
noise

diabetes Clinical Trials

A listing of diabetes medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,606 clinical trials
D Daniel H van Raalte, Prof. Dr.

DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes

SGLT2 inhibitors have demonstrated to mitigate cardiorenal risk in people with type 2 diabetes and are likely to play an increasingly large role in the treatment of patients with diabetes, chronic kidney disease and hypertension. Yet the underlying mechanisms of its protective effects are incompletely understood and the salutary effect …

18 - 85 years of age All Phase 4
L Laurie T Quinn, PhD

Enhancing Diabetes Care: Exposome &Amp; Sensors

The study aims to integrate various data types, such as electronic health records, wearable device data, and environmental data, to create a comprehensive, personalized diabetes care model. The study will focus on people with type 2 diabetes living in specified vulnerable zip codes.

18 - 65 years of age All Phase N/A
B Berna DINCER, PhD

The Effect of Emotional Freedom Technique on Psychological Health and Well-being in People With Type 2 Diabetes.

Type 2 diabetes is a major meatbolic condition. People living with Type 2 diabetes come across a wide range of health issues, including psychological health. Specifically, diabetes distress are in high levels among them. Diabetes distress is associated with psychological states such as anxiety, lower levels of self-care, and higher …

18 years of age All Phase N/A
A Aurora Merovci, MD

SGLT2i, Pioglitazone, and Ketone Production in T2D

To examine whether the empagliflozin-induced stimulation of EGP, lipolysis, and ketone production in T2D individuals can be blocked by pioglitazone (which has direct hepatic and adipose tissue effects).

30 - 75 years of age All Phase 1

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

This trial is conducted in Indonesia. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin in patients with type 2 diabetes

18 - 75 years of age All Phase 3

Personalized Nutrition for Type 2 Diabetes

This project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).

18 years of age All Phase N/A

Glycemic Excursion Minimization (GEM) to Outshine Health Disparities

The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, …

18 years of age All Phase N/A
J Jonathan P Little

The Acute Effect of "Exercise Snacks" on Glycemic Responses in Individuals With Type 2 Diabetes.

To conduct a randomized crossover trial to determine the acute impact of exercise snacks on glycemic control in physically inactive individuals living with type 2 diabetes using continuous glucose monitoring.

30 - 75 years of age All Phase N/A
J Jonathan P Little

Efficacy of Exercise Snacks in Real-World Settings in Individuals Living With Type 2 Diabetes

To conduct a pilot randomized control trial to determine the feasibility of a 12-week, technology-enabled exercise snacks intervention in adults living with type 2 diabetes in a real-world setting. We will also assess preliminary efficacy based on measures of glycemic control and fitness.

30 - 75 years of age All Phase N/A
J Jonathan P Little

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.

To conduct a randomized crossover trial to determine the acute impact of low-intensity movement breaks on glycemic control in physically inactive individuals living with type 2 diabetes using continuous glucose monitoring.

30 - 75 years of age All Phase N/A

Simplify language using AI